IRVINE, Calif., Jan. 7, 2019 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Company"), the world's leading
temperature-controlled logistics company dedicated to the life
sciences industry, is pleased to announce the appointment of
Daniel M. (Dan) Hancock to its Board
of Directors. Mr. Hancock's appointment adds extensive physics
knowledge, engineering and innovation experience, business acumen
and leadership to the Board of Directors. Mr. Hancock will serve on
the Audit Committee, chaired by Richard
Berman, Esq. and the Science and Technology Committee,
chaired by Robert Hariri, PhD,
MD.
Mr. Hancock retired from General Motors ("GM") as Vice President
of Global Strategic Product Alliances responsible for seeking,
defining, negotiating, and implementing strategic collaborations
between GM and other global OEM's and suppliers. He worked at GM
for 43 years. A self-confessed "powertrain guy," Mr. Hancock,
during his tenure, also served as Vice President, Global
Powertrain Engineering; CEO of Fiat-GM Powertrain; and
President of Allison Transmission. Mr. Hancock is an
accomplished engineer and business leader.
Mr. Hancock is also a Board Member of Westport Fuel Systems, a
Vancouver, B.C. based global
supplier of clean gaseous fuel parts, and systems for the
transportation industry. He is also the Board Chairman for
SuperTurbo Technologies, Inc., a Loveland, CO based privately-held developer of
advanced turbocompounding systems for engines and was recently
elected to the Board for Achates Power, Inc., a San Diego, CA headquartered privately-held
developer of innovative opposed-piston, two-stroke diesel engines.
He also serves in an advisory capacity to several global suppliers
to the automotive and commercial vehicle industries.
Jerrell Shelton, Chairman of
Cryoport's Board of Directors, commented, "We are pleased to
welcome Dan to our Board of Directors. His business acumen,
regional knowledge, alliance building experience and technical
knowhow will enable him to provide unique insights as we continue
to develop market-leading practices and invest in building out the
life sciences industry's most advanced temperature-controlled
logistics technology solutions.
"As a matter of practice, Cryoport's Nominating and Governance
Committee regularly evaluates our Board's composition to ensure it
includes the appropriate skills, experience and perspective
necessary to drive value for all our shareholders. Dan will
add an extra dimension to our already highly qualified Board."
Dan Hancock commented, "Cryoport
has done an outstanding job of developing technically advanced
temperature-controlled logistics solutions for the life sciences
industry and is, in fact, at the forefront of this field as
demonstrated by the industry-leading clients it serves. I am
looking forward to working with the board and management in helping
it continue to expand its suite of solutions targeting new areas of
the life sciences market and growing its competitive
advantages."
Mr. Hancock holds a Master of Science in Mechanical Engineering
(MSME) from the Massachusetts Institute of
Technology and a Bachelor of Science in Mechanical
Engineering (BME) from the General Motors Institute (now
Kettering University). He is a
recipient of the Society of Automotive Engineers' Sid Olsen
Engineering Manager Award, the SAE Medal of Honor, the SAE Gordon
Millar Award, the Great Golden Medal for Service to the Republic of
Austria, and the Sagamore of the
Wabash recognition from the
State of Indiana.
About Cryoport, Inc.
Cryoport is a trusted global
provider of solutions for maintaining temperature-sensitive life
sciences commodities during distribution, serving the
biopharmaceutical market with leading-edge logistics solutions for
biologic materials, such as regenerative medicine, including
immunotherapies, stem cells and CAR-T cells. Cryoport's solutions
are used by points-of-care, CRO's, central laboratories,
pharmaceutical companies, manufacturers, university researchers et
al; as well as the reproductive medicine market, primarily in IVF
and surrogacy; and the animal health market, primarily in the areas
of vaccines and reproduction. Cryoport's proprietary Cryoport
Express® Shippers, Cryoportal™ Logistics Management
Platform, leading-edge SmartPak II™ Condition Monitoring System and
geo-sensing technology, paired with unparalleled cold chain
logistics expertise and 24/7 client support, make Cryoport the
end-to-end cold chain logistics partner that the industry
trusts.
Cryoport is dedicated to: simplifying global cold chain
logistics through innovative technology, unmatched monitoring and
data capture and support, including consulting; delivering the most
advanced temperature-controlled logistics solutions for the life
sciences industry; and providing vital information that provides
peace of mind throughout the life of each logistics process.
For more information, visit www.cryoport.com. Sign up to follow
@cryoport on Twitter at www.twitter.com/cryoport.
Forward Looking Statements
Statements in
this news release which are not purely historical, including
statements regarding Cryoport, Inc.'s intentions, hopes, beliefs,
expectations, representations, projections, plans or predictions of
the future are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. It is important
to note that the Company's actual results could differ materially
from those in any such forward-looking statements. Factors that
could cause actual results to differ materially include, but are
not limited to, risks and uncertainties associated with the effect
of changing economic conditions, trends in the products markets,
variations in the Company's cash flow, market acceptance risks, and
technical development risks. The Company's business could be
affected by a number of other factors, including the risk factors
listed from time to time in the Company's SEC reports including,
but not limited to, the Company's 10-K for the year ended
December 31, 2017 filed with the SEC.
The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this press release.
Cryoport, Inc. disclaims any obligation, and does not undertake to
update or revise any forward-looking statements in this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-appoints-daniel-m-hancock-to-board-of-directors-300772749.html
SOURCE Cryoport, Inc.